A07 – Pharmacovigilance: The Australian landscape

This session will provide an overview of current post-market monitoring regulations and practice in Australia. A summary of the biannual ARCS PV survey will be presented, benchmarked against previous surveys. The presentation will focus on changing trends and the implications for future post-market vigilance practice.  This session will also include a TGA speaker discussing post-market monitoring regulations.


Chairperson: Minhaj Obeidullah, Regional Head Patient Safety QA, Novartis